Avanos Medical, Inc.
NYSE:AVNS · New York Stock Exchange
+$0.06 today
Vol 2.54M · Avg 1.49M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+105.95%
Period High
$25.05
Period Low
$9.89
Latest
$24.94
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
CeriBell, Inc.
NASDAQ:CBLL
$664.95M
Bioventus Inc.
NASDAQ:BVS
$587.38M
ClearPoint Neuro, Inc.
NASDAQ:CLPT
$535.60M
Cytek Biosciences, Inc.
NASDAQ:CTKB
$500.43M
4D Molecular Therapeutics, Inc.
NASDAQ:FDMT
$495.06M
Varex Imaging Corporation
NASDAQ:VREX
$437.00M
Community Health Systems, Inc.
NYSE:CYH
$429.09M
Pacific Biosciences of California, Inc.
NASDAQ:PACB
$428.29M
Standard BioTools Inc.
NASDAQ:LAB
$312.33M
Bicycle Therapeutics plc
NASDAQ:BCYC
$276.54M
What is the latest AVNS filing?
The latest filing shown is DEFM14A dated Jun 10, 2026.
How many recent filings does AVNS have?
Intrinsic Alpha currently shows 20 recent filings for AVNS.
Explore More
Continue the stock analysis
Jump to another research area for this company.